Navigation Links
Adding An Additional Drug May Help Patients With Glaucoma

Adding the drug latanoprost, also known as Xalatan, to conventional drugs used to treat the most common form of glaucoma can help reduce dangerous pressure // in the eye that leads to blindness.

Researchers conducted their study among 380 patients with open-angle glaucoma or another form of glaucoma known as exfoliation glaucoma who had originally used the drug in another three-year study. All elected to remain on the drug for another two years so investigators could continue to monitor the safety and effectiveness of the treatment.

Results of the study showed most patients had no increase in iris pigmentation over the five-year period. However, a subgroup of 127 patients, mostly with an eye color known to be susceptible to color change, did see changes in pigmentation. Patients affected by the change were mainly those with two different colors in their irises, such as green-brown or yellow-brown. However the pigmentation changes stabilized over time and patients who experienced pigmentation changes had no more adverse events than those without pigmentation changes and the drug was also found to be just as effective in reducing ocular pressure in patients with pigmentation changes as it was in those without, lowering ocular pressure by about 25 percent.

Thus researchers conclude saying that latanoprost therapy is infact a safe and well tolerated option for long-term treatment of open-angle glaucoma.
'"/>




Page: 1

Related medicine news :

1. Adding contrast improves ultrasounds ability to detect prostate cancer
2. Adding Fish to Diet May Reduce Risk of Alzheimers
3. Adding Credit To The Health Care Industry In India
4. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
5. Adding more fiber in the diet can offset hemorrhoids.
6. Trans Fats Adding Inches to the Waistline
7. Replacing Old Mattress, Adding Ventilation Reduces Mites
8. Adding Radiation Therapy For Treatment of Advanced Prostate Cancer May Offer Benefit
9. Additional Radiotheraphy for Breast Cancer
10. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
11. No More Additional Cases of Mad Cow Disease in Canada
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: